The outcome for children with cancer has shown enormous improvement since the first edition of this book was published in 1975. In economically privileged countries, overall survival rates have now reached 80% at five years from diagnosis, and most of these young people will become long term survivors. The Oxford Textbook of Cancer in Children offers state-of-the-art descriptions of the approach needed for the optimal management of children with cancer, and guidance on current treatments available due to the advances made over the past decade.

This seventh edition has been thoroughly revised and updated, including brand new chapters on cancer immunotherapy in children, and cancer in adolescents and young adults, plus expanded treatment of tumours of the brain and central nervous system. The book primarily provides clear and up-to-date clinical guidance for use in treatment settings whilst offering a useful background to the biology of individual tumour types and the history of the development of specific treatments.

With an international and multi-disciplined authorship comprising of paediatric oncologists, surgeons, radiotherapists, imaging specialists, psychologists, nurses, and many others, the text illustrates how the paediatric oncology community works globally and collaboratively in order to drive forward new therapies, build our knowledge of these diseases, and achieve the common aim of curing childhood cancer. In this new edition, Professors Biondi and Caron have been joined by Professor François Doz, who has a distinguished international reputation, particularly in the treatment of childhood brain tumours and retinoblastoma, as well as early drug development. They have also been joined by Professor Tom Boterberg, a world renowned radio-oncologist for children with cancer.

This book will be of value to paediatric oncologists, trainee paediatric oncologists, paediatric haematologists, and other professionals working in paediatric oncology: nurses, AHPs, surgeons, and clinical oncologists.

� propos de l'auteur

Andrea Biondi M.D., took the degree in Medicine in 1979 at the University of Milano, Italy and in 1982 and 1994 the Specialization in Pediatrics and Haematology respectively. In 1982-84 he was Research Associate in Pathology at the Dana Farber Cancer Institute-Harvard Medical School, Boston, USA. In 1986-1987 he was Research Associate in Medicine at the Ontario Cancer Institute, Toronto, Canada. Since November 2009, he has been the Director of the Department and the School of Paediatrics, University of Milano-Bicocca, San Gerardo Hospital, Monza (MI), Italy. He is head of the M.Tettamanti Research Centre and of S. Verri Cellular and Gene Therapy Laboratory, San Gerardo Hospital, Monza (MI), Italy. Since 2007 he has been Coordinator of the Ph.D. Program in Translational and Molecular Medicine at University of Milano-Bicocca, Milan, Italy. From 2004-08 he was President of SIOP Europe. His clinical and research interests relate to childhood leukaemia and to cell and gene therapy.

Tom Boterberg graduated as an MD in 1994 at Ghent University. After one year of residency in radiation oncology, he worked for 4 years at the Laboratory of Experimental Cancer Research on the biology of the invasive and metastatic behaviour of breast cancer cells. He obtained his PhD in 2000. Afterwards he continued his training in radiation oncology and in 2001 he obtained his Board Certificate in Radiation Oncology. Since 2001 he works as a staff member at the Department of Radiation Oncology at Ghent University Hospital. He is especially interested in paediatric radiotherapy. He is actively involved in the radiotherapy committees of SIOPEN (neuroblastoma) and EpSSG (rhabdomyosarcoma). He is board member of SIOPE and chairs the QUARTET project on quality assurance in paediatric radiotherapy. He is author or co-author of over 100 articles in peer-reviewed journals. His other interests are haematology, neuro-oncology, intra-operative brachytherapy and radioprotection.

Hubert Caron graduated in medicine in 1985 from the Medical School, University of Amsterdam, trained in paediatrics and in paediatric oncology in Emma Children's Hospital, AMC Amsterdam and was appointed professor in paediatric oncology in 2001. He received his PhD (cum laude) in 1995 on the subject "Chromosome 1P in Neuroblastoma: suppressors and prognosis". His main research interests are tumour biology, rational targeted drug design, early new drug trials, systematic reviews of effectiveness of interventions in paediatric oncology and late effects of treatment. Since 2014 he also holds a position as medical director at Roche, where he is responsible for the global clinical development of the oncology portfolio of Roche for children with cancer.

Fran�ois Doz is professor of Paediatrics at the University Paris Descartes and paediatric oncologist at Institut Curie, Paris. He got his MD, paediatric specialty and master in pharmacology in Paris. He then spent two years as a research fellow in the Brain Tumour Research Center, University of California, San Francisco. His main research interests are Paediatric Neuro-oncology, Retinoblastoma, Early Drug Development and Ethics of Clinical Research. He is past- member (2011-2013, 2017) and past-chair (2014-2016) of the SIOP scientific committee, past-chair of the scientific committee of the SFCE (French paediatric cancer society) (2007-2011), member of the SIOPE Board, past- chair of the SIOP-Europe Brain Tumour Group (2006-2010) and of its Medulloblastoma/PNET working group (2013-2016), member of the clinical trial committee and of the executive committee of the ITCC consortium (Innovative Treatment for Children with Cancer) and current co-chair of the European Retinoblastoma Group.

Les informations fournies dans la section � A propos du livre � peuvent faire r�f�rence � une autre �dition de ce titre.

Description de la librairie

Visitez la page d�accueil du vendeur

Informations commerciales relatives au vendeur

Edward Bowditch Ltd
Exstowe, Exton, Exeter, EX3 0PP, United Kingdom

Conditions de vente et de livraison

Conditions g�n�rales de vente

Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch

Droit de r�tractation

Si vous �tes un consommateur, vous pouvez exercer votre droit de r�tractation sur le contrat conform�ment � ce qui suit. Le mot � consommateur � d�signe toute personne physique agissant � des fins qui n'entrent pas dans le cadre de son activit� commerciale, artisanale ou professionnelle.

Informations concernant le droit de r�tractation

Droit statutaire de r�tractation

Vous avez le droit d'exercer votre droit de r�tractation sur ce contrat dans les 14 jours sans donner de raison.

Le d�lai de r�tractation expirera au bout de 14 jours � compter du jour o� vous-m�me, ou un tiers autre que le transporteur et d�sign� par vous, prendrez physiquement possession de la derni�re marchandise, du dernier lot ou de la derni�re pi�ce.

Pour exercer votre droit de r�tractation, remplissez �lectroniquement et envoyez une d�claration claire sur notre site Web, sous � Vos achats � dans � Votre compte �. Nous vous communiquerons sans d�lai un accus� de r�ception de cette r�tractation sur un support durable (par exemple, par e-mail).

Pour respecter le d�lai de r�tractation, il vous suffit d'envoyer votre message concernant l'exercice de votre droit de r�tractation avant l'expiration du d�lai de r�tractation.

Effets de la r�tractation

Si vous exercez votre droit de r�tractation sur ce contrat, nous vous rembourserons tous les paiements que vous avez effectu�s, y compris les frais de livraison (� l'exception des frais suppl�mentaires r�sultant du choix d'un mode de livraison autre que le type de livraison standard le moins cher que nous proposons).

Nous pouvons d�duire du remboursement la perte de valeur de toute marchandise livr�e, si la perte est le r�sultat d'une manipulation inutile de votre part.

Nous effectuerons le remboursement dans les meilleurs d�lais, et au plus tard 14 jours apr�s le jour o� nous aurons �t� inform�s de votre d�cision d'exercer votre droit de r�tractation sur ce contrat.

Nous effectuerons le remboursement en utilisant le m�me moyen de paiement que celui que vous avez utilis� pour la transaction initiale, sauf si vous en avez express�ment convenu autrement ; en tout �tat de cause, aucuns frais ne vous seront factur�s � la suite d'un tel remboursement.

Nous pouvons suspendre le remboursement jusqu'� ce que nous ayons re�u les marchandises ou que vous ayez fourni la preuve que vous avez renvoy� les marchandises, en fonction de la premi�re �ventualit�.

Vous devez renvoyer les marchandises ou les remettre � Revaluation Books, Hounslow, United Kingdom, sans retard injustifi� et, en tout �tat de cause, au plus tard 14 jours � compter du jour o� vous nous avez communiqu� votre d�cision de r�tractation du pr�sent contrat. Le d�lai est respect� si vous renvoyez les marchandises avant l'expiration du d�lai de 14 jours. Vous devrez prendre en charge les frais directs du renvoi des marchandises. Vous n'�tes responsable que de toute diminution de valeur des marchandises r�sultant d'une manipulation autre que celle n�cessaire pour �tablir la nature, les caract�ristiques et le fonctionnement des marchandises.

Exceptions au droit de r�tractation

Le droit de r�tractation ne s'applique pas � ce qui suit :

Distribution de journaux, de revues ou de magazines, � l'exception des contrats d'abonnement ; et
Fourniture d'un contenu num�rique qui n'est pas fourni sur un support mat�riel (par exemple, sur un CD ou un DVD) si vous avez accept�, lors de votre commande, que nous puissions commencer � le livrer et que vous ne puissiez pas exercer votre droit de r�tractation une fois la livraison commenc�e.

Conditions d'exp�dition

Orders usually dispatched within two working days.

Frais d'exp�dition de Royaume-Uni�vers�Etats-Unis

Frais d'exp�dition de Royaume-Uni�vers�Etats-Unis
Quantit� command�e	7 � 14 jours ouvr�s	2 � 3 jours ouvr�s
Premier article	EUR 17.48	EUR 29.13

Les d�lais de livraison sont fix�s par les vendeurs et varient en fonction du transporteur et du lieu. Les commandes transitant par les douanes peuvent �tre retard�es et les acheteurs sont responsables de tous les droits ou frais associ�s. Les vendeurs peuvent vous contacter au sujet de frais suppl�mentaires afin de couvrir toute augmentation des co�ts d'exp�dition de vos articles.